BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/23/2023 6:04:52 PM | Browse: 24 | Download: 38
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 81119
Country/Territory Turkey
Category Oncology
Manuscript Type Retrospective Cohort Study
Article Title Prognostic value of Claudin 18.2 expression in gastric adenocarcinoma
Manuscript Source Unsolicited Manuscript
All Author List Erkan Kayikcioglu, Ramazan Oğuz Yüceer, Bulent Cetin, Kamuran Yüceer and Nermin Karahan
Funding Agency and Grant Number
Corresponding Author Erkan Kayikcioglu, MD, Assistant Professor, Department of Medical Oncology, Suleyman Demirel University, Cunur, Suleyman Demirel Caddesi, Isparta 32260, Turkey. drkayikcioglu@yahoo.com
Key Words Gastric adenocarcinoma; Claudin 18.2; Overall survival; Clinicopathological characteristics
Core Tip Zolbetuximab is a new antibody drug targeting the cell surface protein claudin 18.2 (CLDN 18.2) expressed by gastric cancer cells. CLDN 18.2 expression, identifying the patient population who are susceptible to zolbetuximab, is discordant in different studies. The present study aimed to research the expression ratio of CLDN and its prognostic value for overall survival in patients with gastric adenocarcinoma in a single center located in Turkey.
Citation Kayikcioglu E, Yüceer RO, Cetin B, Yüceer K, Karahan N. Prognostic value of Claudin 18.2 expression in gastric adenocarcinoma. World J Gastrointest Oncol 2023; In press
2022-10-29 10:58
Peer-Review Started
2022-10-29 11:01
To Make the First Decision
Return for Revision
2022-12-30 05:22
2023-01-02 14:44
Second Decision
2023-01-20 03:30
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2023-01-23 18:04
Articles in Press
2023-01-23 18:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
2023-01-29 17:21
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Assistant Editor Assistant Editor
Science Editor Yu-Lu Chen
Reviewer Code 06120334, and 05909109
Editorial Director
Journal Chief Editor
Company Chief Editor Li Ma
Language Editor Donna Fox
Production Editor
Responsible Production Editor
Responsible Science Editor
Proofing Editorial Director Jin-Lei Wang
Proofing Editor-in-Chief Lian-Sheng Ma
Manuscript File 81119-Review-Filipodia.docx
Answering Reviewers 81119-Answering reviewers.pdf
Audio Core Tip 81119-Audio core tip.mp4
Biostatistics Review Certificate 81119-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 81119-Conflict-of-interest statement.pdf
Copyright License Agreement 81119-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s) 81119-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 81119-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 81119-Language certificate.pdf
Peer-review Report 81119-Peer-review(s).pdf
Scientific Misconduct Check 81119-Bing-Chen YL-2.png
Scientific Editor Work List 81119-Scientific editor work list.pdf